Select for export Analysis of recreational psychedelic substance use experiences classified by substance. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06062-3 PubMed 35031816 Copy citation Copy BibTeX Psychopharmacology 2022-01-14 Hase A, Erdmann M, Limbach V, Hasler G. Europe PMC Published psilocybin AddictionBiomarkersEmotional Processing Clinical Trial More
Select for export In Silico Studies on Psilocybin Drug Derivatives Against SARS-CoV-2 and Cytokine Storm of Human Interleukin-6 Receptor. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fimmu.2021.794780 PubMed 35095870 Copy citation Copy BibTeX Frontiers in Immunology 2022-01-13 Khan FI, Hassan F, Lai D. Europe PMC Published psilocybinpsilocin Receptor Pharmacology Other More
Select for export Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-021-06049-6 PubMed 35022823 Copy citation Copy BibTeX Unknown journal 2022-01-12 Bender D, Hellerstein DJ. Europe PMC Published psilocybin Brain ImagingAgingClinical Trial Clinical Trial More
Select for export Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2021.2022817 PubMed 35001856 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2022-01-09 Glynos NG, Pierce J, Davis AK, McAfee J, Boehnke KF. Europe PMC Published psilocybin Chronic PainObservational Study Observational Study More
Select for export MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211058923 PubMed 34983249 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-04 Jones GM, Nock MK. Europe PMC Published psilocybin Observational StudyAdolescentsSafety Observational Study More
Select for export Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211066714 PubMed 34983261 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-04 Jones GM, Nock MK. Europe PMC Published psilocybin DepressionAddictionChronic Pain Observational Study More
Select for export The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211064720 PubMed 35090363 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-03 Rucker JJ, Marwood L, Ajantaival RJ, Bird C, Eriksson H, Harrison J Europe PMC Published psilocybin DepressionReceptor PharmacologyEmotional Processing Randomized Controlled Trial More
Select for export Exploring the Credibility of Psilocybin-assisted Therapy and Cognitive-behavioral Therapy for Depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2021.2020382 PubMed 34979875 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2022-01-02 Altman BR, Earleywine M, De Leo J. Europe PMC Published psilocybin DepressionHealthcare WorkersAdverse Events Other More
Select for export Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulatory effects in healthy humans No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100335 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 Klaus Richter Larsen, Drummond E-Wen McCulloch, Brice Ozenne, Ulrich Lindberg, Sophia Armand, M. Madsen OpenAlex Published psilocybin PharmacologyReceptor Pharmacology Other More
Select for export Rats hallucinate in a similar manner to humans after psilocin No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100950 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 Vejmola Č., Syrová K., Šíchová K., Vlastimil K., Klučková T., Kelemen E. Crossref Published psilocin General Other More
Select for export Psilocybin for the Treatment of Obsessive-Compulsive Disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/7854_2021_279 PubMed 34784024 Copy citation Copy BibTeX Unknown journal 2021-12-31 Ehrmann K, Allen JJB, Moreno FA. Europe PMC Published psilocybin OCDMechanism of ActionReview Article Review Article More
Select for export Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/7854_2021_282 PubMed 34811715 Copy citation Copy BibTeX Current topics in behavioral neurosciences 2021-12-31 Agin-Liebes G, Davis AK. Europe PMC Published psilocybin DepressionBrain ImagingAging Clinical Trial More
Select for export Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2174/1568026621666211201145800 PubMed 34852736 Copy citation Copy BibTeX Current Topics in Medicinal Chemistry 2021-12-31 Sousa TR, Rema J, Machado S, Novais F. Europe PMC Published psilocybin DepressionAnxietyAddiction Randomized Controlled Trial More
Select for export Psychedelic medicines for mood disorders: current evidence and clinical considerations. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/yco.0000000000000759 PubMed 34855694 Copy citation Copy BibTeX PubMed 2021-12-31 Sarris J, Pinzon Rubiano D, Day K, Galvão-Coelho NL, Perkins D. Europe PMC Published psilocybin DepressionPTSDNeuroplasticity Clinical Trial More
Select for export Psilocybin use is associated with lowered odds of crime arrests in US adults: A replication and extension. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211058933 PubMed 35090364 Copy citation Copy BibTeX Journal of Psychopharmacology 2021-12-31 Jones GM, Nock MK. Europe PMC Published psilocybin AddictionPersonality ChangeObservational Study Observational Study More
Select for export Psychedelics in the Treatment of Headache and Chronic Pain Disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/7854_2022_365 PubMed 35546382 Copy citation Copy BibTeX Unknown journal 2021-12-31 Schindler EAD. Europe PMC Published psilocybin Chronic PainHeadache / MigraineReview Article Review Article More
Select for export Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/7854_2022_327 PubMed 35704271 Copy citation Copy BibTeX Unknown journal 2021-12-31 Johnson MW. Europe PMC Published psilocybin AddictionReceptor PharmacologyReview Article Review Article More
Select for export Psilocybin for Trauma-Related Disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/7854_2022_366 PubMed 35711024 Copy citation Copy BibTeX Unknown journal 2021-12-31 Khan AJ, Bradley E, O'Donovan A, Woolley J. Europe PMC Published psilocybin DepressionAnxietyPTSD Other More
Select for export A systematic literature review of clinical trials and therapeutic applications of ibogaine. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jsat.2021.108717 PubMed 35012793 Copy citation Copy BibTeX Unknown journal 2021-12-29 Köck P, Froelich K, Walter M, Lang U, Dürsteler KM. Europe PMC Published psilocybin DepressionAddictionClinical Trial Randomized Controlled Trial More
Select for export LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders: a Randomized, Double-blind, Placebo-controlled Phase II Study Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2021-12-21 University Hospital, Basel, Switzerland ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyEnd-of-Life Distress Clinical Trial More
